Almitas Capital’s Lyell Immunopharma LYEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.13M Buy
579,997
+455,867
+367% +$4.03M 1.29% 16
2025
Q1
$1.34M Buy
124,130
+71,604
+136% +$770K 0.44% 41
2024
Q4
$672K Buy
+52,526
New +$672K 0.15% 63